Abstract
Carpal Tunnel Syndrome (CTS) is popular conditions in where compression of the median nerve causes symptoms such as pain, numbness, and hand weakness in the hand. Current treatments provide varying degree of symptom relief; however, most are limited by short term response or long recovery. Ultrasound-Guided Hydrodissection (USGH) has emerged as a minimally invasive alternative for treating CTS, allowing precise injection of fluid around the median nerve under real-time ultrasound guidance to enhance nerve mobility. Complications of USGH are rare and mild, including short term pain, swelling, or bruising at the injection site. Because of the precision afforded by ultrasound guidance, serious complications, such as nerve damage or infection, are rare. This review aimed to evaluate the long-term clinical outcomes and patient satisfaction after USGH for CTS.